Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Ainos, Inc. (AIMD : NSDQ)

• Company Description    Ainos Inc. is a diversified healthcare company. It engaged in the discovery and development of pharmaceutical and biotech products. The company introduce novel products that actively stimulate and rejuvenate the human body to combat disease and enhance the ability to heal. Ainos Inc., formerly known as Amarillo Biosciences Inc., is based in AMARILLO, TX. Number of Employees: 41

• Price / Volume Information    Yesterday's Closing Price: $1.53 Daily Weekly Monthly 20 Day Moving Average: 19,118 shares Shares Outstanding: 8.52 (millions) Market Capitalization: $13.04 (millions) Beta: 2.29 52 Week High: $4.50 52 Week Low: $1.26 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -14.04% -18.24% 12 Week -7.83% -14.79% Year To Date -6.71% -11.43%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 3050 POST OAK BLVD SUITE 510-T80 - HOUSTON,TX 77056 USA ph: 281-898-6586 fax: 806-376-9301 ir@ainos.com http://www.ainos.com

• General Corporate Information    Officers Chun-Hsien Tsai - Chief Executive Officer; Chairman and President Hsin-Liang Lee - Chief Financial Officer Wen-Han Chang - Director Yao-Chung Chiang - Director Pao-Sheng Wei - Director Peer Information Ainos, Inc. (CHCR) Ainos, Inc. (ESRX) Ainos, Inc. (MYDP) Ainos, Inc. (COR) Ainos, Inc. (GBCS) Ainos, Inc. (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 00902F402 SIC: 3577 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/26 Next Expected EPS Date: 08/12/26 Share - Related Items Shares Outstanding: 8.52 Most Recent Split Date: 6.00 (0.20:1) Beta: 2.29 Market Capitalization: $13.04 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/12/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.29 Price/Cash Flow: - Price / Sales: 105.18 EPS Growth vs. Year Ago Period: 60.95% vs. Previous Quarter: 51.76% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: 450.00% ROE 03/31/26 - -160.55 12/31/25 - -140.10 09/30/25 - -119.36 ROA 03/31/26 - -62.29 12/31/25 - -62.97 09/30/25 - -58.78 Current Ratio 03/31/26 - 0.55 12/31/25 - 1.06 09/30/25 - 2.96 Quick Ratio 03/31/26 - 0.50 12/31/25 - 0.78 09/30/25 - 2.67 Operating Margin 03/31/26 - - 12/31/25 - -11,912.10 09/30/25 - - Net Margin 03/31/26 - - 12/31/25 - -11,912.10 09/30/25 - - Pre-Tax Margin 03/31/26 - -77,466.66 12/31/25 - -11,896.23 09/30/25 - -13,235.40 Book Value 03/31/26 - 0.67 12/31/25 - 1.29 09/30/25 - 2.11 Inventory Turnover 03/31/26 - 0.02 12/31/25 - 0.11 09/30/25 - 0.13 Debt-to-Equity 03/31/26 - 1.58 12/31/25 - 1.45 09/30/25 - 1.10 Debt-to-Capital 03/31/26 - 61.26 12/31/25 - 59.26 09/30/25 - 52.27

Powered by Zacks Investment Research ©